Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity

Antje Arnold(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University)
Neuro-Oncology
December 14, 2019
Cited by 36


Related Papers